Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Development of diagnosis].

Shouhei Ogata1, Masahiro Ishii

  • 1Department of Pediatrics, Kitasato University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|February 12, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying Japanese mothers of infants and toddlers at risk of parenting isolation: A validation study of cutoff scores and associated psychosocial measures.

Japan journal of nursing science : JJNS·2026
Same author

A Case of a Child With Persistent Cough Caused by Dental Aspiration.

Clinical case reports·2026
Same author

Delayed Diagnosis of 48XXYY Syndrome: A Case Report Highlighting the Role of G-Banding Cytogenetics.

Journal of UOEH·2025
Same author

Asymmetric dimethylarginine as a predictive marker for resistance to high-dose intravenous immunoglobulin in Kawasaki disease.

European journal of pediatrics·2025
Same author

Characteristics of Kawasaki disease in children with a history of COVID-19.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2025
Same author

A Pediatric Case of Encephalopathy With Hypoglycemia Induced by Coxsackievirus A4 Infection.

The Pediatric infectious disease journal·2024
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Kawasaki disease (KD) is an acute vasculitis in children with unknown causes. While intravenous immunoglobulin (IVIG) is standard treatment, some children remain resistant, posing diagnostic and therapeutic challenges.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Vascular Biology

Context:

  • Kawasaki disease (KD) is a leading cause of acquired heart disease in children.
  • Diagnosis relies on clinical symptoms due to unknown etiology.
  • Standard treatment involves high-dose intravenous immunoglobulin (IVIG) and aspirin.

Purpose:

  • To highlight the challenges in diagnosing Kawasaki disease.
  • To address the issue of initial IVIG resistance in KD patients.
  • To emphasize the need for improved diagnostic and therapeutic strategies for KD.

Summary:

  • Kawasaki disease (KD) is an acute childhood vasculitis of unknown origin.
  • While IVIG treatment reduces fever and coronary artery aneurysm incidence, 10-20% of patients show resistance.

Related Experiment Videos

  • Approximately 5% of children develop coronary aneurysms despite initial treatment.

    • Impact:

    • Improved early diagnosis of KD is crucial.
    • Identifying and managing IVIG-resistant cases is a significant clinical problem.
    • Further research is needed to enhance KD treatment outcomes and prevent cardiac complications.